Rayyan H.
- Country
- Austria
- Department
- University Clinic for Internal Medicine II, Department of Cardiology
Research Overview
Data & Insights
Has run more than one trial at 0 of 15 partner sites.
Specializations
Coronary Artery Disease and Acute Syndromes
The investigator concentrates on ischemic heart conditions, emphasizing the pathophysiology, risk stratification, and therapeutic optimization for patients presenting with Acute Coronary Syndrome and related myocardial events.
- ST-elevation myocardial infarction
- Non‑ST elevation acute coronary syndrome
- Secondary prevention after myocardial infarction
Clinical activities include evaluation of novel antithrombotic strategies and lipid‑lowering interventions within the cardiovascular risk continuum.
Heart Failure and Cardiomyopathies
Focused on both systolic and diastolic dysfunction, the investigator addresses advanced heart failure syndromes and infiltrative cardiomyopathies such as Transthyretin Amyloid Cardiomyopathy and Hypertrophic Cardiomyopathy.
- Management of chronic heart failure with reduced ejection fraction
- Therapeutic targeting of amyloid deposition in the myocardium
- Device‑based interventions for refractory heart failure
Research integrates pharmacologic modulation of neurohormonal pathways and emerging disease‑modifying agents.
Vascular Disease and Hypertension
The investigator’s portfolio includes atherosclerotic disease, elevated lipoprotein(a) burden, and complex hypertension phenotypes, aiming to reduce major adverse cardiovascular events.
- Elevated lipoprotein(a) as a therapeutic target
- Resistant hypertension management
- Peripheral arterial disease risk reduction
Studies often explore novel lipid‑modifying agents and combination antihypertensive regimens.
Transplant Cardiology and Graft Immunology
Within the transplant arena, the investigator evaluates cardiovascular outcomes in heart and lung recipients, with particular attention to Antibody‑Mediated Rejection and graft‑related hemodynamic compromise.
- Immunomodulatory strategies to prevent cardiac allograft rejection
- Hemodynamic monitoring post‑lung transplantation
- Impact of chronic kidney disease on transplant cardiovascular risk
Efforts include biomarker discovery for early detection of graft dysfunction.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.